Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy

Travis B. Lewis, Joel N. Glasgow, Ashley S. Harms, David G. Standaert, David T. Curiel

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Gene-based therapies for neurological diseases continue to develop briskly. As disease mechanisms are elucidated, flexible gene delivery platforms incorporating transcriptional regulatory elements, therapeutic genes and targeted delivery are required for the safety and efficacy of these approaches. Adenovirus serotype 5 (Ad5)-based vectors can carry large genetic payloads to provide this flexibility, but do not transduce neuronal cells efficiently. To address this, we have developed a tropism-modified Ad5 vector with neuron-selective targeting properties for evaluation in models of Parkinson disease therapy. A panel of tropism-modified Ad5 vectors was screened for enhanced gene delivery in a neuroblastoma cell line model system. We used these observations to design and construct an unbiased Ad vector platform, consisting ofan unmodified Ad5 and a tropism-modified Ad5 vector containing the fiber knob domain from canine Ad serotype 2 (Ad5-CGW-CK2). Delivery to the substantia nigra orstriatum showed that this vector produced a neuronally-restrictedpattern of gene expression. Many of the transduced neurons were from regions with afferent projections to the injection site, implicating that the vector binds the presynaptic terminal resulting in presynaptic transduction. We show that Ad5-CGW-CK2 can selectively transduce neurons in the brain and hypothesize that this modular platform is potentially adaptable to clinical use.

Original languageEnglish
Pages (from-to)3293-3310
Number of pages18
JournalViruses
Volume6
Issue number8
DOIs
StatePublished - Aug 21 2014

Keywords

  • Adenovirus
  • Brain
  • CNS
  • Gene therapy
  • Parkinson disease

Fingerprint Dive into the research topics of 'Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy'. Together they form a unique fingerprint.

Cite this